- Opening of a new 10,000 square-meter building in M'Hamdia
- New clean rooms totalling around 2,400 square meters
M'HAMDIA, Tunisia, May 19, 2022
/PRNewswire/ -- Sartorius, a leading international partner of life
science research and the biopharmaceutical industry, is further
growing its global production capacity with the expansion of its
manufacturing site in Tunisia.
Enabling the Germany-based company
to increase the production of fluid management technologies, it
invested more than 20 million euros
for a new 10,000 square-meter building and corresponding operation
equipment at its existing M'Hamdia location. The extension includes
clean rooms totalling around 2,400 square meters with adjacent
warehouse and logistics facilities, among others. Sartorius
currently has almost 800 employees in M'Hamdia and
anticipates job growth at the site in the future.
The opening ceremony on Thursday, May 19,
2022, was attended by the Governor of Ben Arous, Ezzedine
Chelbi, and the Deputy Head of Mission of the German Embassy
in Tunisia, Georg Felsheim, as well as representatives of
the Ministry of Industry.
"We are significantly investing in the expansion of our
worldwide capacities to meet ongoing high demand from the
biopharmaceutical industry. The new state-of-the-art fluid
management facility in M'Hamdia not only supports this approach but
also demonstrates our long-term commitment to Tunisia", said René Fáber, member of the
Executive Board for the Bioprocess Solutions Division of Sartorius,
on the occasion of the official opening of the new building.
"I am very proud that this project has been completed on time
and with great quality. The commitment and collaboration of
M'Hamdia's teams is tremendous and I am really looking forward to
developing the new expansion together. The increase in capacity
will strengthen our importance within the Sartorius production
network," said Mohamed Yassine Bouagila, Managing Director and Head
of Operations at Sartorius Tunisia.
The site in Tunisia has been in
operation since 2001. In 2019, Sartorius established the Sartorius
Academy Tunisia, a training center to develop the skills of its
employees, especially for new employees joining the plant.
A profile of Sartorius
The Sartorius Group is a leading international partner of life
science research and the biopharmaceutical industry. With
innovative laboratory instruments and consumables, the Group's Lab
Products & Services Division concentrates on serving the needs
of laboratories performing research and quality control at pharma
and biopharma companies and those of academic research institutes.
The Bioprocess Solutions Division with its broad product portfolio
focusing on single-use solutions helps customers to manufacture
biotech medications and vaccines safely and efficiently. The Group
has been annually growing by double digits on average and has been
regularly expanding its portfolio by acquisitions of complementary
technologies. In fiscal 2021, the company earned sales revenue of
some 3.45 billion euros. At the end of 2021, nearly 14,000
people were employed at the Group's approximately
60 manufacturing and sales sites, serving customers around the
globe.
Follow Sartorius on Twitter @Sartorius_Group and on
LinkedIn.
Contact
Timo Lindemann
Press Relations
+49 (0)551 308 4724
timo.lindemann@sartorius.com
Logo -
https://mma.prnewswire.com/media/1123369/Sartorius_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sartorius-continues-global-capacity-expansion-with-opening-of-extended-plant-in-tunisia-301551129.html
SOURCE Sartorius AG
